Osaka, Japan

Kazuhiro Ohdachi

USPTO Granted Patents = 3 


Average Co-Inventor Count = 9.8

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuhiro Ohdachi: Innovator in Heterocyclic Compounds and Benzazepine Derivatives

Introduction

Kazuhiro Ohdachi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on heterocyclic compounds and benzazepine derivatives. With a total of 3 patents to his name, Ohdachi continues to push the boundaries of pharmaceutical research.

Latest Patents

One of his latest patents involves a novel heterocyclic compound that exhibits aryl hydrocarbon receptor antagonist activity. This compound is particularly useful for promoting platelet production and is represented by a specific general formula. Another significant patent focuses on benzazepine derivatives, which are novel compounds that demonstrate vasopressin V1 and V2 antagonism, offering potential medical applications. These compounds are characterized by their unique structural formulas, which include various substituents and hydrocarbon rings.

Career Highlights

Kazuhiro Ohdachi is currently employed at Otsuka Pharmaceutical Company, Limited, where he applies his expertise in drug development and innovation. His work has been instrumental in advancing therapeutic options in the pharmaceutical industry.

Collaborations

Throughout his career, Ohdachi has collaborated with notable colleagues, including Keizo Kan and Masatoshi Takuwa. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Kazuhiro Ohdachi's contributions to the field of medicinal chemistry are noteworthy, particularly in the development of heterocyclic compounds and benzazepine derivatives. His innovative work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…